-
In a study designed to evaluate potential methods for improving survival by prevention of infection in ICU patients, de Smet et al used cluster randomization involving 13 centers in the Netherlands, with assignment to one of three treatment arms: selective decontamination of the gastrointestinal tract (SDD), selective oropharyngeal decontamination (SOD), or standard of care (SOC).
-
Concerns have been raised that immigrants, especially those who are undocumented, afraid of deportation or who have limited financial resources, may be reluctant to present for care, thus compounding the risk for contagious diseases.
-
-
There is an obvious ethical reason why AIDS Drug Assistance Programs (ADAPs) should prioritize client services according to treating the sickest first. However, a researcher also finds a public health and economic reason for such a change.
-
In this new economy of doing more with less money, a 17-year-old peer education and skills training program sponsored by AIDS Service Center (ASC) of New York, NY, is a good model.
-
The peer education and skills training program at AIDS Service Center (ASC) in New York, NY, has helped to change the lives of many people living with HIV infection.
-
Patients enrolled in the Swiss HIV cohort study, initiating their first cART regimen between 1996 and early 2007, who had baseline and follow up CD4+ count and HIV RNA data available, were included in the analysis.
-
The AIDS Drug Assistances Protocol Fund Medical Advisory Committee's Recommendations for State ADAP Waiting List Guidelines, revised in September, 2004, suggest these prioritization strategies for clients who are on waiting lists to receive AIDS Drug Assistance Program (ADAP) drugs to treat their HIV disease:
-
In a case that recalls the national hue and cry of the Florida HIV dental outbreak in the early 1990s, investigators have determined that HIV provider-to-patient infections remain exceedingly rare.
-
On Dec. 30, 2008, the Food and Drug Administration (FDA) approved the first nucleic acid test (NAT) that screens for the presence of two divergent types of HIV in donated blood plasma and human tissue.
